Secondary hematologic malignancies with poly adenosine diphosphate ribose polymerase inhibitors: Is the buzz real? -Insights from a meta-analysis of phase 3 randomized controlled trials

Ball Somedeb; Sultan Anita; Zaw Myo H.; Thein Kyaw Z.

首页> 外文期刊>Journal of geriatric oncology >Secondary hematologic malignancies with poly adenosine diphosphate ribose polymerase inhibitors: Is the buzz real? -Insights from a meta-analysis of phase 3 randomized controlled trials

【24h】

Secondary hematologic malignancies with poly adenosine diphosphate ribose polymerase inhibitors: Is the buzz real? -Insights from a meta-analysis of phase 3 randomized controlled trials

机译：二次血液学恶性肿瘤与聚腺苷二磷酸核糖聚合酶抑制剂：嗡嗡声真实吗？ - 来自第3阶段随机对照试验的META分析的

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of geriatric oncology》 |2019年第3期|共3页
作者
Ball Somedeb; Sultan Anita; Zaw Myo H.; Thein Kyaw Z.;
展开▼
作者单位

Texas Tech Univ Hlth Sci Ctr Dept Internal Med 3601 4th St Lubbock TX 79430 USA;

Texas Tech Univ Hlth Sci Ctr Div Hematol &

Oncol Lubbock TX 79430 USA;

Univ Iowa Dept Internal Med Iowa City IA 52242 USA;

Texas Tech Univ Hlth Sci Ctr Div Hematol &

Oncol Lubbock TX 79430 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
Ovarian neoplasms; PARP inhibitors; Niraparib; Rucaparib; Acute myeloid leukemia; Meta-analysis;

机译：卵巢肿瘤;PARP抑制剂;Niraparib;Rucaparib;急性髓性白血病;Meta分析;

相似文献

外文文献
中文文献
专利

1. Secondary hematologic malignancies with poly adenosine diphosphate ribose polymerase inhibitors: Is the buzz real? -Insights from a meta-analysis of phase 3 randomized controlled trials [J] . Ball Somedeb, Sultan Anita, Zaw Myo H., Journal of geriatric oncology . 2019,第3期

机译：二次血液学恶性肿瘤与聚腺苷二磷酸核糖聚合酶抑制剂：嗡嗡声真实吗？ - 来自第3阶段随机对照试验的META分析的
2. A randomized, placebo-controlled trial to evaluate the tolerability, safety, pharmacokinetics, and pharmacodynamics of a potent inhibitor of poly(ADP-ribose) polymerase (INO-1001) in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of the TIMI 37 trial [J] . David A. Morrow, Chaim M. Brickman, Sabina A. Murphy, Journal of Thrombosis and Thrombolysis . 2009,第4期

机译：一项随机，安慰剂对照试验，评估强（ADP-核糖）聚合酶抑制剂（INO-1001）在ST抬高型心肌梗死患者中接受原发性经皮冠状动脉介入治疗的耐受性，安全性，药代动力学和药效学：结果TIMI 37试验
3. A randomized, placebo-controlled trial to evaluate the tolerability, safety, pharmacokinetics, and pharmacodynamics of a potent inhibitor of poly(ADP-ribose) polymerase (INO-1001) in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of the TIMI 37 trial. [J] . Morrow DA, Brickman CM, Murphy SA Journal of thrombosis and thrombolysis . 2009,第4期

机译：一项随机，安慰剂对照试验，评估强（ADP-核糖）聚合酶抑制剂（INO-1001）在ST抬高型心肌梗死患者中接受原发性经皮冠状动脉介入治疗的耐受性，安全性，药代动力学和药效学：结果TIMI 37试验。
4. Discovery, evolution, and clinical use of poly(adenosine-diphosphate-ribose)polymerase-1,2 (PARP-1,2) inhibitors. [D] . Jang, KyungMin. 2012

机译：聚（腺苷二磷酸核糖）聚合酶-1，2（PARP-1，2）抑制剂的发现，发展和临床应用。
5. Prognostic and clinicopathological value of poly (adenosine diphosphate-ribose) polymerase expression in breast cancer: A meta-analysis [O] . Weiqiang Qiao, Linlin Pan, Changgui Kou, -1

机译：聚腺苷二磷酸核糖聚合酶表达在乳腺癌中的预后和临床病理价值：一项荟萃分析
6. Poly(ADP-Ribose) Polymerase Inhibitors (PARPi) for Patients With Advanced Breast Cancer: a Meta-analysis of Randomized Controlled Trials [O] . YongCheng Su, XiaoGang Zheng 2020

机译：用于晚期乳腺癌患者的聚（ADP-核糖）聚合酶抑制剂（PARPI）：随机对照试验的荟萃分析

Secondary hematologic malignancies with poly adenosine diphosphate ribose polymerase inhibitors: Is the buzz real? -Insights from a meta-analysis of phase 3 randomized controlled trials

著录项

相似文献

相关主题

期刊订阅